Dallas’ MB2 Dental Raises $2.3 Billion Debt Facility with KKR To Fund Acquisitions and Growth

MB2 Dental—a "first-of-its-kind" dental partnership organization—said the financing will be used to fund upcoming acquisitions and future growth for the company. The move follows a record year of growth in 2023 with 150 new partnerships added.

Dallas-based MB2 Dental has closed a $2.344 billion unitranche debt facility with credit vehicles and accounts managed by KKR, which it said acted as lead investor and arranger for the deal.

MB2 Dental, a leading dental partnership organization, said the financing will be used to fund upcoming acquisitions and future growth for the company, following a record year of growth in 2023 with 150 new partnerships.

“MB2 Dental’s access to this new credit facility demonstrates a true endorsement of our strong historical performance and confidence in our growth pipeline,” founder and CEO Dr. Chris Steven Villanueva said in a statement. “We’re seeing unprecedented interest in our partnership model that allows doctors to combine the benefits of joining a larger community with the independence that they love about private practice. The new financing will further accelerate our ability to disrupt the dental profession and continue our nationwide expansion as the fastest-growing dental group in the country.”

Unitranche debt is a type of structured debt that receives funding from multiple participants and has varying term structures.

In May 2023, MB2 Dental announced it raised a record $20 million for its ninth internal investment “sidecar” vehicle, allowing its doctor partners to invest in the company’s growth. MB2 said at that time that it closed an amendment to its existing debt facility, securing a new delayed-draw term loan of $150 million.

MB2 said that it planned to use those funds to expand its network of over 550 practices across 38 states and support upcoming acquisitions.

MB2 Dental, which calls itself a first-of-its-kind dental partnership organization, was founded and led by Villaneuva, a dentist and entrepreneur.

Since its founding in 2007, MB2 Dental has partnered with more than 685 general and specialty dental practices across 39 states.

Get on the list.
Dallas Innovates, every day.

Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day.

One quick signup, and you’re done.  

R E A D   N E X T

  • From its scrappy beginnings in Texas in 2007, MB2 Dental has grown into a nationwide network of over 550 practices across 38 states. The organization's doctor partners are also shareholders, giving them financial freedom and a say in decision-making for patient care. With a record-breaking $20M fundraising round and a new $150M debt facility, the DPO is poised for more growth.

  • Dallas has proven to be an ideal home base for Cypress Growth Capital, Quincy Preston wrote last week in Dallas Innovates. The firm's unique model is defying norms in the funding landscape by fostering rapid growth without diluting entrepreneurial control.

  • CEO James Range shares insights on the company's journey from one customer to more than 2,500 in tech hubs across the country.

  • Dallas Growth Advisory SBI Appoints New Chief Consulting Officer

    SBI, a go-to-market growth advisory, has named Alicia Lee as its new Chief Consulting Officer. With over two decades of consulting leadership experience, Lee will play a key role in scaling and advancing SBI's consulting delivery capabilities, the company said in a news release. SBI CEO Mike Hoffman called Lee's consulting track record "remarkable." The executive, with her 22 years in executive consulting roles, has "deep expertise" in growth and works collaboratively across different lines of business, making her a "top choice to bring innovative new best practices to SBI." Besides consulting, Lee has experience in product management, process optimization,…

  • Dallas-based Cypress Growth Capital is defying norms in the funding landscape. Not your traditional venture capitalist, this trailblazing firm hit a landmark with its 50th portfolio investment—and fourth major play this year—a $4 million stake in medical records disruptor, ChartSquad. Managing Director Vik Thapar peels back the curtain on the firm's unique model, which fosters rapid growth without diluting entrepreneurial control.